You Searched For "Oxford coronavirus" and got 20 results
Sort By:
Oxford researchers are seeking volunteers willing to get COVID-19 deliberately for a human challenge trial
Britain is the first country to conduct a human challenge trial, exposing people to a low dose of t…
Andrea Michelson
Coronavirus epidemic first hit over 21,000 years ago, says a study
The most recent common ancestor of sarbecoviruses — the family of coronaviruses to which SARS-CoV b…
UK study states that Oxford/AstraZeneca vaccine is 80% effective against B1.617.2 variant of the Coronavirus
According to The Telegraph' newspaper, the latest study's findings were presented to a meeting…
PTI
Scientists uncover more data on blood clotting side effect of Covid jab
Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting co…
PTI
How AstraZeneca and Oxford blew their vaccine moment
These are Business Insider's biggest healthcare stories for November 30.
Lydia Ramsey Pflanzer
The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla
The CEO of Serum Institute of India (SII), the company conducting the clinical trials of the vac…
Oxford's COVID-19 vaccine is safe and produces an immune response in older adults, encouraging early trial results suggest
Results of phase 3 trials — which will show whether the Oxford University vaccine can prevent COVID…
Grace Dean
Oxford’s COVID-19 vaccine: Phase III human trials begin in India
Serum Institute is likely to conduct the Phase III trials on 1,500 volunteers across 14 locati…
Serum Institute of India can resume clinical trial of Oxford COVID-19 vaccine, says DCGI
SII has also been asked to submit to the DCGI's office details of medication used in accordance wit…
PTI
Australia begins production of Oxford-developed Covid-19 vaccine
Despite still undergoing clinical trials, the vaccine, which was co-developed by pharmaceutical …
Oxford-Astrazeneca COVID-19 Vaccine: Phase II trials will begin in India today
"To start with we have identified five volunteers who will undergo COVID-19 and antibodies tests…
Serum Institute may begin human trials of Oxford-AstraZeneca’s COVID-19 vaccine candidate from August 25
The trials will be held at PGIMER Chandigarh, AIIMS in Delhi, ABJ Medical College in Pune, Rajen…
One dose of Pfizer or AstraZeneca vaccine was highly effective at preventing coronavirus in older people, real-world data from South Korea suggests
It is not clear from South Korea's data how long protection against COVID-19 from a single shot las…
Dr. Catherine Schuster-Bruce
AstraZeneca's missteps and murky data sewed worldwide confusion that undermined trust - but don't rule the shot out yet
How effective is AstraZeneca's vaccine? That's not fully clear yet. It depends on the dosing and th…
Aria Bendix
Oxford and Serum Institute of India begin human trials of a new COVID-19 vaccine in Australia
According to Sumi Biswas, CEO SpyBiotech, the Serum Institute of India — which is running the ph…
Serum Institute insists Covishield is the most affordable vaccine in the market today; says price has been increased so that they can invest into scaling up production
It currently charges the central government ₹150 per dose for the existing supplies. The…
PTI
One dose of the AstraZeneca or Pfizer vaccine provides protection against COVID-19 that lasts at least 10 weeks, study finds
One dose of a Pfizer-BioNTech or AstraZeneca-Oxford vaccine reduced COVID-19 infections by 65% in a…
Dr. Catherine Schuster-Bruce
Watch: Insider answers your questions about the risk of rare but serious blood clots following some COVID-19 vaccines
Insider discussed the risks and benefits of COVID-19 vaccines from AstraZeneca and Johnson & Johnso…
Dr. Catherine Schuster-Bruce,…
AstraZeneca's COVID-19 vaccine enters Phase-III trial in the US
The Covid-19 vaccine candidate developed by Oxford University in partnership with the UK-based g…
The Oxford COVID-19 vaccine will soon be tested on children as young as 6
It's the first vaccine research to be carried out in children so young, following Pfizer and Modern…